4//SEC Filing
Litvack Frank 4
Accession 0001415889-25-006736
CIK 0001133869other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:00 PM ET
Size
10.2 KB
Accession
0001415889-25-006736
Insider Transaction Report
Form 4
Litvack Frank
Director
Transactions
- Tax Payment
Common Stock
2025-03-03$13.67/sh−2,543$34,763→ 129,839 total - Exercise/Conversion
Common Stock
2025-03-03$1.39/sh+25,000$34,750→ 132,382 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-03-03−25,000→ 0 totalExercise: $1.39Exp: 2025-03-03→ Common Stock (25,000 underlying)
Holdings
- 46,278(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on March 3, 2025 of $13.67. The options would otherwise expire on March 3, 2025, pursuant to their terms.
- [F2]Held by Litvack Curtis Family Trust for which the Reporting Person serves as trustee.
- [F3]This option was granted on March 3, 2015 and was previously reported as covering 250,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
- [F4]Shares vested 1/48th on the first day of each month commencing April 1, 2015.
Documents
Issuer
CAPRICOR THERAPEUTICS, INC.
CIK 0001133869
Entity typeother
Related Parties
1- filerCIK 0001310715
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:00 PM ET
- Size
- 10.2 KB